Browsing byAuthor윤채옥

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 91 to 120 of 166

Issue DateTitleAuthor(s)
2020-04Nose-to-Brain Delivery of Cancer-Targeting Paclitaxel-Loaded Nanoparticles Potentiates Antitumor Effects in Malignant Glioblastoma윤채옥
2011-08A Novel Combination Treatment of Armed Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Radiotherapy in Murine Hepatocarcinoma윤채옥
2012-05A Novel sLRP6E1E2 Inhibits Canonical Wnt Signaling, Epithelial-to-Mesenchymal Transition, and Induces Mitochondria-Dependent Apoptosis in Lung Cancer윤채옥
2013-01A novel three-dimensional model system for keloid study: Organotypic multicellular scar model윤채옥
2019-09Oncolytic Ad co-expressing decorin and Wnt decoy receptor overcomes chemoresistance of desmoplastic tumor through degradation of ECM and inhibition of EMT윤채옥
2011-09Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12R beta(2) or IL-18R alpha윤채옥
2015-07Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy윤채옥
2017-01Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model윤채옥
2015-12Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model윤채옥
2016-12Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function adn enhances antitumor efficacy.윤채옥
2013-07Oncolytic Adenovirus Expressing IL-23 and p35 Elicits IFN-gamma- and TNF-a-Co-Producing T Cell-Mediated Antitumor Immunity윤채옥
2017-06Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer윤채옥
2020-11Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials윤채옥
2020-04Optimising Hydrogel Release Profiles for Viro-Immunotherapy Using Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Immature Dendritic Cells윤채옥
2017-08Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy윤채옥
2021-08Optimizing Active Tumor Targeting Biocompatible Polymers for Efficient Systemic Delivery of Adenovirus윤채옥
2011-08Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF윤채옥
2021-02Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspective윤채옥
2019-07Overcoming the limitations of locally administered oncolytic virotherapy윤채옥
2022-03A pH-and Bioreducible Cationic Copolymer with Amino Acids and Piperazines for Adenovirus Delivery윤채옥
2015-05pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis윤채옥
2019-10Physically crosslinked injectable hydrogels for long-term delivery of oncolytic adenoviruses for cancer treatment윤채옥
2021-01Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic윤채옥
2015-12Polymeric oncolytic adenovirus for cancer gene therapy윤채옥
2022-02Polymeric Systems for Cancer Immunotherapy: A Review윤채옥
2021-12Polypeptide-Based K+Ionophore as a Strong Immunogenic Cell Death Inducer for Cancer Immunotherapy윤채옥
2015-11Potent and long-term antiangiogenic efficacy mediated by FP3-expressing oncolytic adenovirus윤채옥
2015-12Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model윤채옥
2018-01Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer윤채옥
2018-05Profibrogenic effect of high-mobility group box protein-1 in human dermal fibroblasts and its excess in keloid tissues윤채옥

BROWSE